CPC A61K 38/14 (2013.01) [A61K 9/0019 (2013.01); A61K 47/02 (2013.01); A61P 31/04 (2018.01)] | 2 Claims |
1. A glycopeptide compound having activity of resisting drug-resistant bacteria of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), characterized in that, conforming glycopeptide compounds shown in general formula I:
or a pharmaceutically acceptable salt thereof, wherein:
R represents by the following formula: -A-D-E-G; wherein:
A is a benzene ring;
D is —O— or —NH—;
E is —(CH2)m-, wherein m is 1 to 3;
G is the structural formula:
wherein L is any one of halogen, trifluoromethyl, and methoxy.
|